Pharma Neuigkeiten

Boehringer Ingelheim
Family-owned pharmaceutical company Boehringer Ingelheim has presented its latest pipeline updates at a Research & Development press conference entitled 'Transcending Disease Boundaries', at its global headquarters in Ingelheim, Germany. The company's R&D strategy and current pipeline has the potential to deliver 15 new medicines for approval by 2025 (probability adjusted). [...]
Do, Apr 26, 2018
Source Pharma News
Novartis
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients. By adapting the design of clinical trials to suit the daily routine of patients, the app [...]
Mi, Apr 25, 2018
Source Pharma News
The rabies virus wreaks havoc on the brain, triggering psychosis and death. To get where it needs to go, the virus must first trick the nervous system and cross the blood brain barrier - a process that makes it of interest in drug design. Now, scientists report in ACS Nano [...]
Mi, Apr 25, 2018
Source Pharma News
Using sunlight for sustainable and cheap production of, for example, medicines. The 'mini-factory' in the form of a leaf that chemical engineers from Eindhoven University of Technology presented in 2016 showed that it is possible. Now the researchers have come with an improved version: their 'mini-factory' is now able to [...]
Di, Apr 24, 2018
Source Pharma News

(von Worldpharmanews)

Kontaktieren Sie uns
Dispopharm D&P Ltd.
Gewerbestrasse 18
4123 Allschwil
Schweiz
Telefon: +41 61 487 96 36
Fax. +41 61 487 96 20
dispopharm@dispopharm.com
Dates
No dates at the moment.